$REFI
Chicago Atlantic Real Estate Finance, Inc.

2023 Q4 Form 10-Q Financial Statement

#000121390023084499 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $16.60M $15.18M $15.99M
YoY Change 3.78% 17.37% 176.74%
Cost Of Revenue $1.691M $1.450M $1.231M
YoY Change 37.33% 68.34%
Gross Profit $14.91M $13.73M $14.76M
YoY Change 0.98% 6.16%
Gross Profit Margin 89.81% 90.45% 92.3%
Selling, General & Admin $5.763M $3.880M $5.023M
YoY Change 14.72% 35.76% 327.98%
% of Gross Profit 38.66% 28.26% 34.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.510M $3.840M $7.507M
YoY Change -26.61% 21.34% 442.01%
Operating Profit $9.398M $9.890M $7.256M
YoY Change 29.52% 1.24%
Interest Expense $1.449M
YoY Change 102.64%
% of Operating Profit 14.65%
Other Income/Expense, Net
YoY Change
Pretax Income $9.398M $9.977M $7.256M
YoY Change 29.52% 2.13% 66.4%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $9.398M $9.977M $7.256M
YoY Change 29.52% 2.13% 66.4%
Net Earnings / Revenue 56.62% 65.72% 45.37%
Basic Earnings Per Share $0.55
Diluted Earnings Per Share $0.51 $0.54 $0.41
COMMON SHARES
Basic Shares Outstanding 18.18M shares 18.18M shares 17.66M shares
Diluted Shares Outstanding 18.56M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.898M $8.700M $5.716M
YoY Change 38.18% -6.77% -92.88%
Cash & Equivalents $7.900M $8.702M $5.716M
Short-Term Investments
Other Short-Term Assets $107.2K
YoY Change
Inventory $1.204M
Prepaid Expenses
Receivables
Other Receivables $327.8K $3.285M $100.4K
Total Short-Term Assets $8.711M $12.90M $6.734M
YoY Change 29.36% 26.77% -91.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $842.3K $3.500M
YoY Change
Other Assets -$4.973M -$5.100M -$3.941M
YoY Change 26.18% -554.01%
Total Long-Term Assets $350.5M $339.4M $336.5M
YoY Change 4.15% 2.76% 70.04%
TOTAL ASSETS
Total Short-Term Assets $8.711M $12.90M $6.734M
Total Long-Term Assets $350.5M $339.4M $336.5M
Total Assets $359.2M $352.3M $343.3M
YoY Change 4.65% 3.47% 23.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.135M $1.200M $1.058M
YoY Change 7.3% 67.49% 397.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $336.3M
YoY Change 67.86%
Total Short-Term Liabilities $18.25M $11.40M $17.97M
YoY Change 1.52% 8.58% 217.76%
LONG-TERM LIABILITIES
Long-Term Debt $66.00M $63.00M $58.00M
YoY Change 13.79% 18.87%
Other Long-Term Liabilities $3.126M $2.200M $3.266M
YoY Change -4.27% -67.78% -61.29%
Total Long-Term Liabilities $69.13M $65.20M $61.27M
YoY Change 12.83% 8.98% 626.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.25M $11.40M $17.97M
Total Long-Term Liabilities $69.13M $65.20M $61.27M
Total Liabilities $87.37M $76.52M $79.24M
YoY Change 10.27% 8.81% 462.27%
SHAREHOLDERS EQUITY
Retained Earnings -$5.812M -$1.343M -$5.140M
YoY Change 13.07% -223.47% 2794.62%
Common Stock $277.7M $277.1M $176.9K
YoY Change 156897.98% 156842.75% 1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $271.9M $275.8M $264.0M
YoY Change
Total Liabilities & Shareholders Equity $359.2M $352.3M $343.3M
YoY Change 4.65% 3.47% 23.4%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income $9.398M $9.977M $7.256M
YoY Change 29.52% 2.13% 66.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $15.50M $1.000M $4.627M
YoY Change 235.05% -80.01% -183.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$10.74M -$21.71M -$4.519M
YoY Change 137.63% 987.95% -91.07%
Cash From Investing Activities -$10.74M -$21.71M -$4.519M
YoY Change 137.63% 987.95% -91.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.568M 11.38M -3.724M
YoY Change 49.54% -3903.22% -102.91%
NET CHANGE
Cash From Operating Activities 15.50M 1.000M 4.627M
Cash From Investing Activities -10.74M -21.71M -4.519M
Cash From Financing Activities -5.568M 11.38M -3.724M
Net Change In Cash -804.1K -9.330M -3.616M
YoY Change -77.76% -444.48% -105.05%
FREE CASH FLOW
Cash From Operating Activities $15.50M $1.000M $4.627M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
339273538 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41123
CY2023Q3 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
341813501 usd
dei Entity Registrant Name
EntityRegistrantName
CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3125132
dei Entity Address Address Line1
EntityAddressAddressLine1
1680 Michigan Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33139
dei City Area Code
CityAreaCode
(312)
dei Local Phone Number
LocalPhoneNumber
809-7002
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
REFI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18182241 shares
CY2023Q3 refi Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment
322513760 usd
CY2022Q4 refi Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment
339273538 usd
CY2023Q3 refi Loan Held For Investment Related Party
LoanHeldForInvestmentRelatedParty
16278729 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
338792489 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
339273538 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
5112195 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
3940939 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
333680294 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
335332599 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8702157 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5715827 usd
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3469340 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
2226902 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
946077 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1018212 usd
CY2023Q3 us-gaap Assets
Assets
352309670 usd
CY2022Q4 us-gaap Assets
Assets
343271050 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
63000000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
58000000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
8568252 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
13618591 usd
CY2023Q3 us-gaap Management Fee Payable
ManagementFeePayable
1601387 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
3295600 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1187591 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1058128 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
498264 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1868193 usd
CY2023Q3 us-gaap Liabilities
Liabilities
76524277 usd
CY2022Q4 us-gaap Liabilities
Liabilities
79238027 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18182241 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18182241 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17766936 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17766936 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
181823 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
176859 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
276946111 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
268995848 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1342541 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5139684 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
275785393 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
264033023 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
352309670 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
343271050 usd
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
15183450 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
13795097 usd
us-gaap Interest Income Operating
InterestIncomeOperating
46369976 usd
us-gaap Interest Income Operating
InterestIncomeOperating
35478178 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1449143 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
861348 usd
us-gaap Interest Expense
InterestExpense
4062365 usd
us-gaap Interest Expense
InterestExpense
1383172 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13734307 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12933749 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42307611 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
34095006 usd
CY2023Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1601387 usd
CY2022Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1347421 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5539059 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
3266487 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1251307 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1076798 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3833733 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2410151 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
491107 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
348785 usd
us-gaap Professional Fees
ProfessionalFees
1598376 usd
us-gaap Professional Fees
ProfessionalFees
1649360 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
540426 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
84891 usd
us-gaap Share Based Compensation
ShareBasedCompensation
942605 usd
us-gaap Share Based Compensation
ShareBasedCompensation
328356 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-41351 usd
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
306885 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1403892 usd
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
3842876 usd
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
3164780 usd
us-gaap Noninterest Expense
NoninterestExpense
13107653 usd
us-gaap Noninterest Expense
NoninterestExpense
9058246 usd
CY2023Q3 refi Change In Unrealized Gains On Debt Securities At Fair Value
ChangeInUnrealizedGainsOnDebtSecuritiesAtFairValue
85567 usd
refi Change In Unrealized Gains On Debt Securities At Fair Value
ChangeInUnrealizedGainsOnDebtSecuritiesAtFairValue
112767 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9976998 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9768969 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29312725 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25036760 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9976998 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9768969 usd
us-gaap Net Income Loss
NetIncomeLoss
29312725 usd
us-gaap Net Income Loss
NetIncomeLoss
25036760 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.6
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.41
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18175467 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17657913 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18052293 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17652367 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18562930 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17752290 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18269171 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17747612 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273689874 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
540426 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
8421905 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9976998 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
275785393 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
268627511 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
95484 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
8339170 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9768969 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
270152794 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
264033023 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1222352 usd
refi Stock Issued During Period Connection With Private Placement Net Of Offering Costs Underwritting Discountand Commission
StockIssuedDuringPeriodConnectionWithPrivatePlacementNetOfOfferingCostsUnderwrittingDiscountandCommission
5794847 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
942675 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
25520229 usd
us-gaap Net Income Loss
NetIncomeLoss
29312725 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
275785393 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
264077968 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4481556 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
340131 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.34
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
23783621 usd
us-gaap Net Income Loss
NetIncomeLoss
25036760 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
270152794 usd
us-gaap Net Income Loss
NetIncomeLoss
29312725 usd
us-gaap Net Income Loss
NetIncomeLoss
25036760 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1989374 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2139972 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6343749 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
4096721 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1193880 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1403892 usd
refi Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value
ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue
-112767 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
405778 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
379644 usd
us-gaap Share Based Compensation
ShareBasedCompensation
942605 usd
us-gaap Share Based Compensation
ShareBasedCompensation
328356 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1022490 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
529544 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
146364 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
172699 usd
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
-1369929 usd
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
-9940290 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
271268 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1100201 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3824900 usd
us-gaap Increase Decrease In Debt Securities Trading
IncreaseDecreaseInDebtSecuritiesTrading
3356573 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1694213 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
545127 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
106839 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
463075 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12912736 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12377829 usd
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
67422648 usd
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
134314003 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13399712 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
6696777 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
62837108 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
6892654 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8814172 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-120724572 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7222363 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4505664 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
64000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
53000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
59000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
30566088 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
19874715 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
112279 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
177261 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
284574 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23941 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18740578 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37429747 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2986330 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-70916996 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5715827 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80248526 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8702157 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9331530 usd
refi Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
1007910 usd
refi Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
8929716 usd
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
1676017 usd
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
2180593 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8568252 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8409628 usd
us-gaap Mortgage Loan Related To Property Sales1
MortgageLoanRelatedToPropertySales1
13399712 usd
us-gaap Interest Paid Net
InterestPaidNet
3530521 usd
us-gaap Interest Paid Net
InterestPaidNet
646278 usd
us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.90 pure
CY2023Q3 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-3021012 usd
CY2023Q3 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
333680294 usd
CY2022Q4 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
343029334 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
149086 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><i>Use of Estimates in the Preparation of Consolidated Financial Statements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</p>
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3778000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3356573 usd
CY2023Q3 refi Available For Sale Debt Securities Unamortized Discount
AvailableForSaleDebtSecuritiesUnamortizedDiscount
421427 usd
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3469340 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
112767 usd
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><i>Revenue Recognition</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Interest income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the outstanding face amount and the contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to the amortized cost and accreted or amortized as an adjustment to interest income using a method that approximates the effective interest method. Realized gains or losses on debt securities are measured by the difference between the net proceeds from the disposition and the amortized and/or accreted cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include loans charged off during the period, net of recoveries.</p>
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3284900 usd
us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.90 pure
us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
1 pure
refi Effective Of Ordinary Income Percentage
EffectiveOfOrdinaryIncomePercentage
0.85 pure
refi Effective Income Tax Rate Capital Gain Net Income
EffectiveIncomeTaxRateCapitalGainNetIncome
0.95 pure
refi Effective Income Tax Rate Reconciliation Non Deductible Excise Tax
EffectiveIncomeTaxRateReconciliationNonDeductibleExciseTax
0.04 pure
refi Effective Income Tax Rate Reconciliation Distribution Of Net Capital Gains
EffectiveIncomeTaxRateReconciliationDistributionOfNetCapitalGains
0.90 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
CY2023Q3 refi Principal New Fundings
PrincipalNewFundings
32800000 usd
refi Principal New Fundings
PrincipalNewFundings
68700000 usd
CY2023Q3 refi Portfolio Percentage
PortfolioPercentage
0.811 pure
CY2022Q4 refi Portfolio Percentage
PortfolioPercentage
0.831 pure
CY2023Q3 us-gaap Debt Current
DebtCurrent
274400000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
281600000 usd
CY2023Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.189 pure
CY2022Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.169 pure
CY2023Q3 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
64400000 usd
CY2022Q4 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
57700000 usd
CY2023Q3 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
341813501 usd
CY2023Q3 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-3021012 usd
CY2023Q3 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
338792489 usd
us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y2M12D
CY2023Q3 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
-5112195 usd
CY2022Q4 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-3755796 usd
CY2022Q4 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
339273538 usd
CY2022 us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y2M12D
CY2022Q4 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
-3940939 usd
CY2022Q4 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
343029334 usd
CY2022Q4 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-3755796 usd
CY2022Q4 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
335332599 usd
CY2022Q4 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
335332599 usd
refi New Fundings
NewFundings
67422648 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
62837108 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1989374 usd
CY2023Q3 refi Principal Sale Of Loans
PrincipalSaleOfLoans
13399712 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6343749 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
1171256 usd
CY2023Q3 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
333680294 usd
refi Loan Commitment
LoanCommitment
355941661 usd
refi Outstanding Principal
OutstandingPrincipal
341813501 usd
refi Original Issue Premium Discount
OriginalIssuePremiumDiscount
-3021012 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
333680294 usd
refi Percentof Our Loan Portfolio
PercentofOurLoanPortfolio
1 pure
refi Future Fundings
FutureFundings
11204000 usd
refi Periodic Payment
PeriodicPayment
Wtd Average
refi Yieldto Maturityof Internal Rateof Return
YieldtoMaturityofInternalRateofReturn
0.193 pure
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
338792489 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
338792489 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
339273538 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
339273538 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
1 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
0 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
1300000 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
45358655 usd
CY2022Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
155849851 usd
CY2021Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
137583983 usd
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
338792489 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
124882562 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
185250430 usd
CY2020Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
29140546 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1300000 usd
CY2023Q3 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
338792489 usd
CY2022Q4 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
339273538 usd
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4035354 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880 usd
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
5229234 usd
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
147949 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1403892 usd
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
1551841 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
2226902 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
2195375 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1203330 usd
CY2023Q3 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
31527 usd
CY2022Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
1082 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
2226902 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
2226902 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
2226902 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16300000 usd
us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
991694 usd
CY2023Q3 refi Unused Fee Expense
UnusedFeeExpense
26174 usd
CY2022Q3 refi Unused Fee Expense
UnusedFeeExpense
7667 usd
refi Unused Fee Expense
UnusedFeeExpense
67875 usd
refi Unused Fee Expense
UnusedFeeExpense
11834 usd
CY2022Q4 refi Interest Reserves
InterestReserves
1868193 usd
CY2021Q4 refi Interest Reserves
InterestReserves
6636553 usd
refi New Reserves
NewReserves
1007910 usd
CY2022 refi New Reserves
NewReserves
9049834 usd
refi Reserve Disbursed
ReserveDisbursed
2377839 usd
CY2022 refi Reserve Disbursed
ReserveDisbursed
13818194 usd
CY2023Q3 refi Interest Reserves
InterestReserves
498264 usd
CY2022Q4 refi Interest Reserves
InterestReserves
1868193 usd
CY2021Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
100000 usd
us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
On December 16, 2021, CAL entered into an amended and restated Revolving Loan agreement (the “First Amendment and Restatement”). The First Amendment and Restatement increased the loan commitment from $10,000,000 to $45,000,000 and decreased the interest rate, from the greater of the (1) Prime Rate plus 1.00% and (2) 4.75% to the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The First Amendment and Restatement also extended the maturity date from February 12, 2023 to the earlier of (i) December 16, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to the terms of the Revolving Loan agreement.
CY2021Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
859500 usd
CY2022Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
177261 usd
CY2022Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
323779 usd
CY2023Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2988 usd
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
516261 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
805596 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
5000000 usd
us-gaap Financing Receivable Revolving Converted To Term Loan During Period
FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod
37 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1276292 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
715132 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
3588712 usd
CY2023Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
146677 usd
CY2022Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
138549 usd
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
405778 usd
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
379644 usd
CY2023Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1449143 usd
CY2022Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-861348 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-4062365 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1383172 usd
us-gaap Management Fee Description
ManagementFeeDescription
The Manager is entitled to receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375% of the Company’s Equity, determined as of the last day of each such quarter; reduced by an amount equal to 50% of the pro rata amount of origination fees earned and paid to the Manager during the applicable quarter for loans that were originated on the Company’s behalf by the Manager or affiliates of the Manager (“Outside Fees”).
refi Outside Fees Earned
OutsideFeesEarned
130000 usd
CY2022Q3 refi Outside Fees Earned
OutsideFeesEarned
192751 usd
refi Outside Fees Earned
OutsideFeesEarned
1275001 usd
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026 usd
CY2022Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
519223 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1500129 usd
CY2023Q3 refi Management Fees Earned
ManagementFeesEarned
1055421 usd
CY2022Q3 refi Management Fees Earned
ManagementFeesEarned
1020949 usd
refi Management Fees Earned
ManagementFeesEarned
3137033 usd
refi Management Fees Earned
ManagementFeesEarned
3041359 usd
CY2022Q3 refi Outside Fees Earned
OutsideFeesEarned
192751 usd
refi Outside Fees Earned
OutsideFeesEarned
130000 usd
refi Outside Fees Earned
OutsideFeesEarned
1275001 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1055421 usd
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
828198 usd
us-gaap Management Fee Expense
ManagementFeeExpense
3007033 usd
us-gaap Management Fee Expense
ManagementFeeExpense
1766358 usd
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966 usd
CY2022Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
519223 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1500129 usd
CY2023Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1601387 usd
CY2022Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1347421 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5539059 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
3266487 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1144907 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
980949 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3533493 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2132419 usd
CY2023Q3 us-gaap Affiliate Costs
AffiliateCosts
2746294 usd
CY2022Q3 us-gaap Affiliate Costs
AffiliateCosts
2328370 usd
us-gaap Affiliate Costs
AffiliateCosts
9072552 usd
us-gaap Affiliate Costs
AffiliateCosts
5398906 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
3300000 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
4700000 usd
CY2023Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
800000 usd
refi Assigned Right Sold Amount
AssignedRightSoldAmount
237885 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
19300000 usd
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
19000000 usd
us-gaap Selling Expense
SellingExpense
14200000 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13400000 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
16300000 usd
CY2023Q3 refi Original Loan Commitments
OriginalLoanCommitments
355941661 usd
CY2022Q4 refi Original Loan Commitments
OriginalLoanCommitments
351367706 usd
CY2023Q3 refi Less Drawn Commitments
LessDrawnCommitments
344737661 usd
CY2022Q4 refi Less Drawn Commitments
LessDrawnCommitments
336323706 usd
CY2023Q3 refi Undrawn Commitments
UndrawnCommitments
11204000 usd
CY2022Q4 refi Undrawn Commitments
UndrawnCommitments
15044000 usd
CY2023Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
70000000 usd
CY2023Q3 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
204000 usd
CY2023Q3 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
4000000 usd
CY2023Q3 us-gaap Other Commitment
OtherCommitment
74204000 usd
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
1147 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
13438 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
5632476 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
705956 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
80984 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
323452 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
20648 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1147 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
16
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
382641 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.88
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
98440 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
13438 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
16
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
85002 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
942605 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
328356 usd
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
5067401 usd
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
1078216 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
75000000 usd
refi Gross Proceeds Percentage
grossProceedsPercentage
0.03 pure
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
9976998 usd
CY2022Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
9768969 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
29312725 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
25036760 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18175467 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17657913 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18052293 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17652367 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18562930 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17752290 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18269171 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17747612 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.6
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.41
us-gaap Income Tax Holiday Description
IncomeTaxHolidayDescription
To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax.
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3469340 usd
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
334835555 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
329237824 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3956935 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
10035714 usd
us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
8500000 usd
CY2022Q4 refi Loan Held For Investment Related Party
LoanHeldForInvestmentRelatedParty
usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
refi Change In Unrealized Gains On Debt Securities At Fair Value
ChangeInUnrealizedGainsOnDebtSecuritiesAtFairValue
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q3 refi Stock Issued During Period Connection With Private Placement Net Of Offering Costs Underwritting Discountand Commission
StockIssuedDuringPeriodConnectionWithPrivatePlacementNetOfOfferingCostsUnderwrittingDiscountandCommission
usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
refi Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value
ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue
usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
us-gaap Increase Decrease In Debt Securities Trading
IncreaseDecreaseInDebtSecuritiesTrading
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
us-gaap Mortgage Loan Related To Property Sales1
MortgageLoanRelatedToPropertySales1
usd
CY2023Q3 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
usd
CY2023Q3 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
usd
CY2022Q4 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
usd
CY2022Q4 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
usd
CY2023Q3 us-gaap Loans Held For Sale Maturity Date
LoansHeldForSaleMaturityDate
CY2020Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
usd
CY2019Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
usd
CY2019Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
usd
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
usd
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
usd
CY2023Q3 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
usd
CY2023Q3 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001867949

Files In Submission

Name View Source Status
refi-20230930_cal.xml Edgar Link unprocessable
refi-20230930_def.xml Edgar Link unprocessable
0001213900-23-084499-index-headers.html Edgar Link pending
0001213900-23-084499-index.html Edgar Link pending
0001213900-23-084499.txt Edgar Link pending
0001213900-23-084499-xbrl.zip Edgar Link pending
f10q0923ex31-1_chicagoatl.htm Edgar Link pending
f10q0923ex31-2_chicagoatl.htm Edgar Link pending
f10q0923ex32-1_chicagoatl.htm Edgar Link pending
f10q0923ex32-2_chicagoatl.htm Edgar Link pending
f10q0923_chicagoatl.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0923_chicagoatl_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
refi-20230930.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
refi-20230930_lab.xml Edgar Link unprocessable
refi-20230930_pre.xml Edgar Link unprocessable